UK Biotech Financing Hits Five-Year High in Q2 2026
The UK biotech sector experienced strong recovery in Q2 2026 with equity financing reaching £2.11bn, a five-year high driven largely by venture capital investment. Isomorphic Lab's record-breaking £1.6bn funding round highlighted the growth, while overall private fundraising nearly doubled compared to the same period in 2025.
Topics: drug development financing recovery UK biotech venture capital